Mechanistic basis for functional promiscuity in the TNF and TNF Receptor superfamilies: Structure of the light:DcR3 assembly

Structure

Volumn 22, Issue 9, 2014, Pages 1252-1262

  Liu, Weifeng ^a   Zhan, Chenyang ^a   Cheng, Huiyong ^a   Kumar, P Rajesh ^a   Bonanno, Jeffrey B ^a   Nathenson, Stanley G ^a   Almo, Steven C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DCR3 PROTEIN; HERPESVIRUS ENTRY MEDIATOR; LIGHT PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; DECOY RECEPTOR 3; HERPESVIRUS ENTRY MEDIATOR LIGAND; PROTEIN BINDING; TNFRSF6B PROTEIN, HUMAN; TNFSF14 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HERPES SIMPLEX VIRUS; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; CHEMICAL STRUCTURE; CHEMISTRY; CONSERVED SEQUENCE; HT 29 CELL LINE; HUMAN; HYDROGEN BOND; METABOLISM; MOLECULAR GENETICS; PROTEIN DOMAIN; PROTEIN QUATERNARY STRUCTURE; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; CONSERVED SEQUENCE; CRYSTALLOGRAPHY, X-RAY; HT29 CELLS; HUMANS; HYDROGEN BONDING; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STRUCTURE, QUATERNARY; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 6B; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14;

EID: 84930188892     PISSN: 09692126     EISSN: 18784186     Source Type: Journal    
DOI: 10.1016/j.str.2014.06.013     Document Type: Article

References (42)

1. P.D. Adams, P.V. Afonine, G. Bunkóczi, V.B. Chen, I.W. Davis, N. Echols, J.J. Headd, L.W. Hung, G.J. Kapral, and R.W. Grosse-Kunstleve et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution Acta Crystallogr. D Biol. Crystallogr. 66 2010 213 221
2. A. Ashkenazi Targeting death and decoy receptors of the tumour-necrosis factor superfamily Nat. Rev. Cancer 2 2002 420 430
3. K. Bendtzen Anti-TNF-α biotherapies: perspectives for evidence-based personalized medicine Immunotherapy 4 2012 1167 1179
4. J.L. Browning, K. Miatkowski, I. Sizing, D. Griffiths, M. Zafari, C.D. Benjamin, W. Meier, and F. Mackay Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines J. Exp. Med. 183 1996 867 878
5. G. Cai, and G.J. Freeman The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation Immunol. Rev. 229 2009 244 258
6. Y.H. Chang, S.L. Hsieh, M.C. Chen, and W.W. Lin Lymphotoxin beta receptor induces interleukin 8 gene expression via NF-kappaB and AP-1 activation Exp. Cell Res. 278 2002 166 174
7. Y.C. Chang, Y.H. Chan, D.G. Jackson, and S.L. Hsieh The glycosaminoglycan-binding domain of decoy receptor 3 is essential for induction of monocyte adhesion J. Immunol. 176 2006 173 180
8. M.C. Chen, M.J. Hwang, Y.C. Chou, W.H. Chen, G. Cheng, H. Nakano, T.Y. Luh, S.C. Mai, and S.L. Hsieh The role of apoptosis signal-regulating kinase 1 in lymphotoxin-beta receptor-mediated cell death J. Biol. Chem. 278 2003 16073 16081
9. T.C. Cheung, K. Coppieters, H. Sanjo, L.M. Oborne, P.S. Norris, A. Coddington, S.W. Granger, D. Elewaut, and C.F. Ware Polymorphic variants of LIGHT (TNF superfamily-14) alter receptor avidity and bioavailability J. Immunol. 185 2010 1949 1958
10. J.P. Connor, M. Felder, A. Kapur, and N. Onujiogu DcR3 binds to ovarian cancer via heparan sulfate proteoglycans and modulates tumor cells response to platinum with corresponding alteration in the expression of BRCA1 BMC Cancer 12 2012 176
11. M.J. Eck, and S.R. Sprang The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding J. Biol. Chem. 264 1989 17595 17605
12. P. Emsley, B. Lohkamp, W.G. Scott, and K. Cowtan Features and development of Coot Acta Crystallogr. D Biol. Crystallogr. 66 2010 486 501
13. B. Funke, F. Autschbach, S. Kim, F. Lasitschka, U. Strauch, G. Rogler, G. Gdynia, L. Li, N. Gretz, and S. Macher-Goeppinger et al. Functional characterisation of decoy receptor 3 in Crohn's disease Gut 58 2009 483 491
14. H. Hasegawa, and L. Holm Advances and pitfalls of protein structural alignment Curr. Opin. Struct. Biol. 19 2009 341 348
15. S. Hayashi, Y. Miura, T. Nishiyama, M. Mitani, K. Tateishi, Y. Sakai, A. Hashiramoto, M. Kurosaka, S. Shiozawa, and M. Doita Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis Arthritis Rheum. 56 2007 1067 1075
16. M.J. Hsu, W.W. Lin, W.C. Tsao, Y.C. Chang, T.L. Hsu, A.W. Chiu, C.C. Chio, and S.L. Hsieh Enhanced adhesion of monocytes via reverse signaling triggered by decoy receptor 3 Exp. Cell Res. 292 2004 241 251
17. T.L. Hsu, Y.Y. Wu, Y.C. Chang, C.Y. Yang, M.Z. Lai, W.B. Su, and S.L. Hsieh Attenuation of Th1 response in decoy receptor 3 transgenic mice J. Immunol. 175 2005 5135 5145
18. Y.S. Kim, S.A. Nedospasov, and Z.G. Liu TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling Mol. Cell. Biol. 25 2005 2130 2137
19. E. Krissinel, and K. Henrick Inference of macromolecular assemblies from crystalline state J. Mol. Biol. 372 2007 774 797
20. D.N. Mauri, R. Ebner, R.I. Montgomery, K.D. Kochel, T.C. Cheung, G.L. Yu, S. Ruben, M. Murphy, R.J. Eisenberg, and G.H. Cohen et al. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator Immunity 8 1998 21 30
21. T. Morishige, Y. Yoshioka, H. Inakura, A. Tanabe, X. Yao, S. Tsunoda, Y. Tsutsumi, Y. Mukai, N. Okada, and S. Nakagawa Creation of a LIGHT mutant with the capacity to evade the decoy receptor for cancer therapy Biomaterials 31 2010 3357 3363
22. Y. Mukai, T. Nakamura, M. Yoshikawa, Y. Yoshioka, S. Tsunoda, S. Nakagawa, Y. Yamagata, and Y. Tsutsumi Solution of the structure of the TNF-TNFR2 complex Sci. Signal. 3 2010 ra83
23. G.N. Murshudov, A.A. Vagin, and E.J. Dodson Refinement of macromolecular structures by the maximum-likelihood method Acta Crystallogr. D Biol. Crystallogr. 53 1997 240 255
24. Z. Otwinowski, and W. Minor Processing of X-ray diffraction data collected in oscillation mode Methods Enzymol. 276 1997 307 326
25. I.A. Rooney, K.D. Butrovich, A.A. Glass, S. Borboroglu, C.A. Benedict, J.C. Whitbeck, G.H. Cohen, R.J. Eisenberg, and C.F. Ware The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells J. Biol. Chem. 275 2000 14307 14315
26. R.B. Shaikh, S. Santee, S.W. Granger, K. Butrovich, T. Cheung, M. Kronenberg, H. Cheroutre, and C.F. Ware Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction J. Immunol. 167 2001 6330 6337
27. T. Spoettl, M. Hausmann, F. Klebl, A. Dirmeier, B. Klump, J. Hoffmann, H. Herfarth, A. Timmer, and G. Rogler Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients Inflamm. Bowel Dis. 13 2007 727 732
28. K. Tamada, K. Shimozaki, A.I. Chapoval, Y. Zhai, J. Su, S.F. Chen, S.L. Hsieh, S. Nagata, J. Ni, and L. Chen LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response J. Immunol. 164 2000 4105 4110
29. M.G. Tansey, and D.E. Szymkowski The TNF superfamily in 2009: new pathways, new indications, and new drugs Drug Discov. Today 14 2009 1082 1088
30. J. Wang, J.C. Lo, A. Foster, P. Yu, H.M. Chen, Y. Wang, K. Tamada, L. Chen, and Y.X. Fu The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT J. Clin. Invest. 108 2001 1771 1780
31. Y. Wang, E.P. Koroleva, A.A. Kruglov, D.V. Kuprash, S.A. Nedospasov, Y.X. Fu, and A.V. Tumanov Lymphotoxin beta receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection Immunity 32 2010 403 413
32. C.F. Ware Network communications: lymphotoxins, LIGHT, and TNF Annu. Rev. Immunol. 23 2005 787 819
33. M.D. Winn, C.C. Ballard, K.D. Cowtan, E.J. Dodson, P. Emsley, P.R. Evans, R.M. Keegan, E.B. Krissinel, A.G. Leslie, and A. McCoy et al. Overview of the CCP4 suite and current developments Acta Crystallogr. D Biol. Crystallogr. 67 2011 235 242
34. Y. Wu, B. Han, H. Sheng, M. Lin, P.A. Moore, J. Zhang, and J. Wu Clinical significance of detecting elevated serum DcR3/TR6/M68 in malignant tumor patients Int. J. Cancer 105 2003 724 732
35. R.I. You, Y.C. Chang, P.M. Chen, W.S. Wang, T.L. Hsu, C.Y. Yang, C.T. Lee, and S.L. Hsieh Apoptosis of dendritic cells induced by decoy receptor 3 (DcR3) Blood 111 2008 1480 1488
36. H.A. Young, and M.G. Tovey TL1A: a mediator of gut inflammation Proc. Natl. Acad. Sci. USA 103 2006 8303 8304
37. K.Y. Yu, B. Kwon, J. Ni, Y. Zhai, R. Ebner, and B.S. Kwon A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis J. Biol. Chem. 274 1999 13733 13736
38. Y. Zhai, R. Guo, T.L. Hsu, G.L. Yu, J. Ni, B.S. Kwon, G.W. Jiang, J. Lu, J. Tan, and M. Ugustus et al. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer J. Clin. Invest. 102 1998 1142 1151
39. C. Zhan, Q. Yan, Y. Patskovsky, Z. Li, R. Toro, A. Meyer, H. Cheng, M. Brenowitz, S.G. Nathenson, and S.C. Almo Biochemical and structural characterization of the human TL1A ectodomain Biochemistry 48 2009 7636 7645
40. C. Zhan, Y. Patskovsky, Q. Yan, Z. Li, U. Ramagopal, H. Cheng, M. Brenowitz, X. Hui, S.G. Nathenson, and S.C. Almo Decoy strategies: the structure of TL1A:DcR3 complex Structure 19 2011 162 171
41. J. Zhang, T.W. Salcedo, X. Wan, S. Ullrich, B. Hu, T. Gregorio, P. Feng, S. Qi, H. Chen, and Y.H. Cho et al. Modulation of T-cell responses to alloantigens by TR6/DcR3 J. Clin. Invest. 107 2001 1459 1468
42. X. Zhang, J.C. Schwartz, S.C. Almo, and S.G. Nathenson Expression, refolding, purification, molecular characterization, crystallization, and preliminary X-ray analysis of the receptor binding domain of human B7-2 Protein Expr. Purif. 25 2002 105 113